BMC Surgery · 2024 · 15 citations · 23 references
MedicineAnesthesiologyPerioperative MedicineAnesthesiaEnhanced Recovery After SurgeryShoulder SurgeryArthroscopic Shoulder SurgeryPostoperative NauseaShoulder ArthroscopyAnesthesia For Shoulder SurgeryDexmedetomidine AnalgesiaOpioid-based Intravenous AnesthesiaOpioid-free AnesthesiaPostoperative Nausea ManagementRemifentanil InfusionShoulder Surgery AnalgesiaUltrasound-guided Brachial Plexus Block
BACKGROUND: OFA (Opioid-free anesthesia) has the potential to reduce the occurrence of opioid-related adverse events and enhance postoperative recovery. Our research aimed to investigate whether OFA, combining esketamine and dexmedetomidine, could serve as an alternative protocol to traditional OBA (opioid-based anesthesia) in shoulder arthroscopy, particularly in terms of reducing PONV (postoperative nausea and vomiting). METHODS: A total of 60 patients treated with shoulder arthroscopy from September 2021 to September 2022 were recruited. Patients were randomly assigned to the OBA group (n = 30) and OFA group (n = 30), receiving propofol-remifentanil TIVA (total intravenous anesthesia) and esketamine-dexmedetomidine intravenous anesthesia, respectively. Both groups received ultrasound-guided ISBPB(interscalene brachial plexus block)for postoperative analgesia. RESULTS: The incidence of PONV on the first postoperative day in the ward (13.3% vs. 40%, P < 0.05) was significantly lower in the OFA group than in the OBA group. Moreover, the severity of PONV was less severe in the OFA group than in the OBA group in PACU (post-anesthesia care unit) (0 [0, 0] vs. 0 [0, 3], P<0.05 ) and in the ward 24 h postoperatively ( 0 [0, 0] vs. 0 [0, 2.25], P<0.05). Additionally, the OFA group experienced a significantly shorter length of stay in the PACU compared to the OBA group (39.4 ± 6.76 min vs. 48.7 ± 7.90 min, P < 0.001). CONCLUSIONS: Compared to the OBA with propofol-remifentanil, the OFA with esketamine- dexmedetomidine proved to be feasible for shoulder arthroscopy, resulting in a reduced incidence of PONV and a shorter duration of stay in the PACU. TRIAL REGISTRATION: The Chinese Clinical Trial Registry (No: ChiCTR2100047355), 12/06/2021.
23
A Simplified Risk Score for Predicting Postoperative Nausea and Vomiting
Christian C. Apfel, Esa Läärä, M. Koivuranta et al. · Anesthesiology · 1999 · 2.1K citations · Full text
Medicine, Anesthesiology, Surgery +17
Eric S. Schwenk, Eugene R. Viscusi, Asokumar Buvanendran et al. · Regional Anesthesia & Pain Medicine · 2018 · 576 citations · Full text
Glenn S. Murphy, Joseph W. Szokol, Jesse H. Marymont et al. · Anesthesia & Analgesia · 2010 · 256 citations
Ketamine: A tale of two enantiomers
Luke A. Jelen, Allan H. Young, James Stone · Journal of Psychopharmacology · 2020 · 243 citations · Full text
Medicine, Pharmacology, Psychiatry +16